AOAC-03 Preliminary Program

KEYNOTE ADDRESS

U.S. PARTICIPATION IN CODEX ALIMENTARIUS, THE ROLE OF STANDARD DEVELOPING ORGANIZATIONS MONDAY, SEPTEMBER 19, 2016  |  10:30 AM – 12:00 PM Greg Noonan, Ph.D., Director, Division of Bioanalytical Chemistry Food and Drug Administration, U.S. Food and Drug Administration ‘Codex Alimentarius ’, or the “Food Code”, primary goal is to protect consumer health by developing and implementing international standards, codes of practice, and guidelines related to safe and high quality food. The U.S., led by the U.S. Codex

Office (USDA), engages with the 180 plus members of Codex Alimentarius through involvement with nearly 20 General Subject and Commodity Committees. A critical part of the U.S. engagement relies on a variety of stakeholders, including consumers, NGOs, industry and Standard Development Organizations (SDOs) such as AOAC INTERNATIONAL. While safety can’t be tested into food, methods of analysis are a critical component to verifying that food meets both safety and quality standards agreed to by international trading partners. AOAC INTERNATIONAL Official Methods are heavily relied upon and have been “endorsed” by the Codex Committee on Methods of Analysis and Sampling (CCMAS) for inclusion in numerous Codex Standards. However, the development of new commodity standards or new analytical methods means that methods are often reviewed and updated. The acceptance of new methods into Codex Standards requires careful planning, often with multiple Codex Committees, an understanding of Codex procedural rules and patience. AOAC INTERNATIONAL’s continued engagement with U.S. Delegates to Codex Committees and yearly participation in CCMAS is vital to ensuring newly developed methods are properly considered by Codex Committees.

About Dr. Noonan Dr. Gregory Noonan joined the U.S. Food and Drug Administration in 2002 and is currently the Director of the Division of Bioanalytical Chemistry (DBC) in the Office of Regulatory Science. The Division of Bioanalytical Chemistry contains over 35 scientists performing research and developing analytical methods in numerous subject areas, including, toxic elements analysis, immunodiagnostic and DNA- based allergen detection, radionuclides, pesticide analysis, mycotoxin analysis, dietary supplements and botanicals, nutritional ingredients and cosmetics. Prior to becoming Director, Dr. Noonan was a Research Chemist in the Method Development Branch of the Division of Analytical Chemistry. His research focused on developing methods for the determination of food additives, including indirect

additives, and process induced contaminants. Dr. Noonan also serves as the U.S. Delegate to the Codex Committee on Methods of Analysis and Sampling (CCMAS), where he chairs the Working Group on the Endorsement of Methods. Dr. Noonan received his PhD in Chemistry from Michigan State University in 1996. After graduation he worked for the Diagnostic Division of Abbott Laboratories, where he developed diagnostic immunoassays for Hepatitis A, B and C and HIV. After leaving Abbott Laboratories and prior to joining the FDA, he was a postdoctoral fellow in the Civil and Environmental Engineering department of the Massachusetts Institute of Technology, where he studied the fate and transport of polar, water soluble environmental contaminants.

11

www.aoac.org

301.924.7077